Live from the NIH registry
Studies recruiting near York right now
Top 25 of 446 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Penn State Health — Hershey, Pennsylvania (22.6 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (0.3 mi)
· Sponsor: AbbVie
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
Rib Fracture Multiple
N/A
Interventional 60 participants sought
Wellspan Health York Hospital — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Lancaster, Pennsylvania (23.1 mi)
· Sponsor: AstraZeneca
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Giselle Sholler
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Heart and Vascular Research at WellSpan Health — York, Pennsylvania (0.3 mi)
· Sponsor: Eli Lilly and Company
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Penn State Hershey Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: The Society for Pediatric Anesthesia
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Cancer Care Associates of York (site 206) — York, Pennsylvania (0.3 mi)
· Sponsor: VM Oncology, LLC
Clinical Decision Support Tool in PARDS Pilot Study
Ventilation Therapy; Complications, Ventilator-Induced Lung Injury
N/A
Interventional 180 participants sought
Penn State University — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Children's Hospital Los Angeles
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Hershey, Pennsylvania (22.6 mi)
· Sponsor: AstraZeneca
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Penn State Milton S Hershey Medical Ctr — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Janssen Research & Development, LLC
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Camp Hill, Pennsylvania (21.4 mi)
· Sponsor: Enveda Therapeutics
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Children's Hospital - Penn State Hershey — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Children's Hospital of Philadelphia
A Randomized Multicenter Study for Isolated Skin Vasculitis
Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa
Phase 2
Interventional 90 participants sought
Penn State Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: University of Pennsylvania
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Penn State Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Children's Oncology Group
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Steba Biotech S.A.
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Lancaster, Pennsylvania (23.1 mi)
· Sponsor: Alnylam Pharmaceuticals
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Osteosarcoma, Ewing Sarcoma
Phase 2
Interventional 406 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Milton S. Hershey Medical Center
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
Cholecystitis, Acute, Biliary Diseases
N/A
Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
WellSpan Health-York Cancer Center — York, Pennsylvania (0.3 mi)
· Sponsor: SWOG Cancer Research Network
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (22.8 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Penn State Hershey — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Novartis Pharmaceuticals
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Endometrial Cancer
N/A
Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Regeneron Pharmaceuticals